Our study showed that activation of NF-κB is crucial for FISS, as evidenced by strong expression detected by ICC/IHC and the inhibitory and anti-proliferative effects by the NF-κB inhibitor. This evidence concerns the gene NFKB1 and intrahepatic cholangiocarcinoma.